Nimesulide
The global Nimesulide market is segmented by company, region (country), by Type, and by Applicati ... Read More
Global Meloxicam Sales Market Report 2024
1 Meloxicam Market Overview
1.1 Meloxicam Product Scope
1.2 Meloxicam Segment by Type
1.2.1 Global Meloxicam Sales by Type (2016 & 2021 & 2027)
1.2.2 Combination Drugs
1.2.3 Prescribed Drugs
1.3 Meloxicam Segment by Application
1.3.1 Global Meloxicam Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Soft Tissue Inflammation
1.3.5 Traumatic Pain
1.3.6 Post-Operative Pain
1.3.7 Other
1.4 Meloxicam Market Estimates and Forecasts (2016-2027)
1.4.1 Global Meloxicam Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Meloxicam Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Meloxicam Price Trends (2016-2027)
2 Meloxicam Estimates and Forecasts by Region
2.1 Global Meloxicam Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Meloxicam Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Meloxicam Sales Market Share by Region (2016-2021)
2.2.2 Global Meloxicam Revenue Market Share by Region (2016-2021)
2.3 Global Meloxicam Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Meloxicam Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Meloxicam Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Meloxicam Estimates and Projections (2016-2027)
2.4.2 Europe Meloxicam Estimates and Projections (2016-2027)
2.4.3 China Meloxicam Estimates and Projections (2016-2027)
2.4.4 Japan Meloxicam Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Meloxicam Estimates and Projections (2016-2027)
2.4.6 India Meloxicam Estimates and Projections (2016-2027)
3 Global Meloxicam Competition Landscape by Players
3.1 Global Top Meloxicam Players by Sales (2016-2021)
3.2 Global Top Meloxicam Players by Revenue (2016-2021)
3.3 Global Meloxicam Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meloxicam as of 2020)
3.4 Global Meloxicam Average Price by Company (2016-2021)
3.5 Manufacturers Meloxicam Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Meloxicam Market Size by Type
4.1 Global Meloxicam Historic Market Review by Type (2016-2021)
4.1.1 Global Meloxicam Sales Market Share by Type (2016-2021)
4.1.2 Global Meloxicam Revenue Market Share by Type (2016-2021)
4.1.3 Global Meloxicam Price by Type (2016-2021)
4.2 Global Meloxicam Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Meloxicam Sales Forecast by Type (2022-2027)
4.2.2 Global Meloxicam Revenue Forecast by Type (2022-2027)
4.2.3 Global Meloxicam Price Forecast by Type (2022-2027)
5 Global Meloxicam Market Size by Application
5.1 Global Meloxicam Historic Market Review by Application (2016-2021)
5.1.1 Global Meloxicam Sales Market Share by Application (2016-2021)
5.1.2 Global Meloxicam Revenue Market Share by Application (2016-2021)
5.1.3 Global Meloxicam Price by Application (2016-2021)
5.2 Global Meloxicam Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Meloxicam Sales Forecast by Application (2022-2027)
5.2.2 Global Meloxicam Revenue Forecast by Application (2022-2027)
5.2.3 Global Meloxicam Price Forecast by Application (2022-2027)
6 North America Meloxicam Market Facts & Figures
6.1 North America Meloxicam Sales by Company
6.1.1 North America Meloxicam Sales by Company (2016-2021)
6.1.2 North America Meloxicam Revenue by Company (2016-2021)
6.2 North America Meloxicam Sales Breakdown by Type
6.2.1 North America Meloxicam Sales Breakdown by Type (2016-2021)
6.2.2 North America Meloxicam Sales Breakdown by Type (2022-2027)
6.3 North America Meloxicam Sales Breakdown by Application
6.3.1 North America Meloxicam Sales Breakdown by Application (2016-2021)
6.3.2 North America Meloxicam Sales Breakdown by Application (2022-2027)
7 Europe Meloxicam Market Facts & Figures
7.1 Europe Meloxicam Sales by Company
7.1.1 Europe Meloxicam Sales by Company (2016-2021)
7.1.2 Europe Meloxicam Revenue by Company (2016-2021)
7.2 Europe Meloxicam Sales Breakdown by Type
7.2.1 Europe Meloxicam Sales Breakdown by Type (2016-2021)
7.2.2 Europe Meloxicam Sales Breakdown by Type (2022-2027)
7.3 Europe Meloxicam Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China Meloxicam Market Facts & Figures
8.1 China Meloxicam Sales by Company
8.1.1 China Meloxicam Sales by Company (2016-2021)
8.1.2 China Meloxicam Revenue by Company (2016-2021)
8.2 China Meloxicam Sales Breakdown by Type
8.2.1 China Meloxicam Sales Breakdown by Type (2016-2021)
8.2.2 China Meloxicam Sales Breakdown by Type (2022-2027)
8.3 China Meloxicam Sales Breakdown by Application
8.3.1 China 316 Sales Breakdown by Application (2016-2021)
8.3.2 China 316 Sales Breakdown by Application (2022-2027)
9 Japan Meloxicam Market Facts & Figures
9.1 Japan Meloxicam Sales by Company
9.1.1 Japan Meloxicam Sales by Company (2016-2021)
9.1.2 Japan Meloxicam Revenue by Company (2016-2021)
9.2 Japan Meloxicam Sales Breakdown by Type
9.2.1 Japan Meloxicam Sales Breakdown by Type (2016-2021)
9.2.2 Japan Meloxicam Sales Breakdown by Type (2022-2027)
9.3 Japan Meloxicam Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Meloxicam Market Facts & Figures
10.1 Southeast Asia Meloxicam Sales by Company
10.1.1 Southeast Asia Meloxicam Sales by Company (2016-2021)
10.1.2 Southeast Asia Meloxicam Revenue by Company (2016-2021)
10.2 Southeast Asia Meloxicam Sales Breakdown by Type
10.2.1 Southeast Asia Meloxicam Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Meloxicam Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Meloxicam Sales Breakdown by Application
10.3.1 Southeast Asia KG Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia KG Sales Breakdown by Application (2022-2027)
11 India Meloxicam Market Facts & Figures
11.1 India Meloxicam Sales by Company
11.1.1 India Meloxicam Sales by Company (2016-2021)
11.1.2 India Meloxicam Revenue by Company (2016-2021)
11.2 India Meloxicam Sales Breakdown by Type
11.2.1 India Meloxicam Sales Breakdown by Type (2016-2021)
11.2.2 India Meloxicam Sales Breakdown by Type (2022-2027)
11.3 India Meloxicam Sales Breakdown by Application
11.3.1 India Meloxicam Sales Breakdown by Application (2016-2021)
11.3.2 India Meloxicam Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Meloxicam Business
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Corporation Information
12.1.2 Boehringer Ingelheim Business Overview
12.1.3 Boehringer Ingelheim Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Boehringer Ingelheim Meloxicam Products Offered
12.1.5 Boehringer Ingelheim Recent Development
12.2 Baudax
12.2.1 Baudax Corporation Information
12.2.2 Baudax Business Overview
12.2.3 Baudax Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Baudax Meloxicam Products Offered
12.2.5 Baudax Recent Development
12.3 Perrigo
12.3.1 Perrigo Corporation Information
12.3.2 Perrigo Business Overview
12.3.3 Perrigo Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Perrigo Meloxicam Products Offered
12.3.5 Perrigo Recent Development
12.4 Recro Pharma
12.4.1 Recro Pharma Corporation Information
12.4.2 Recro Pharma Business Overview
12.4.3 Recro Pharma Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Recro Pharma Meloxicam Products Offered
12.4.5 Recro Pharma Recent Development
12.5 Iroko Pharma
12.5.1 Iroko Pharma Corporation Information
12.5.2 Iroko Pharma Business Overview
12.5.3 Iroko Pharma Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Iroko Pharma Meloxicam Products Offered
12.5.5 Iroko Pharma Recent Development
12.6 Zyla Life Sciences
12.6.1 Zyla Life Sciences Corporation Information
12.6.2 Zyla Life Sciences Business Overview
12.6.3 Zyla Life Sciences Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Zyla Life Sciences Meloxicam Products Offered
12.6.5 Zyla Life Sciences Recent Development
12.7 Axsome Therapeutics
12.7.1 Axsome Therapeutics Corporation Information
12.7.2 Axsome Therapeutics Business Overview
12.7.3 Axsome Therapeutics Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Axsome Therapeutics Meloxicam Products Offered
12.7.5 Axsome Therapeutics Recent Development
12.8 Orbis Biosciences
12.8.1 Orbis Biosciences Corporation Information
12.8.2 Orbis Biosciences Business Overview
12.8.3 Orbis Biosciences Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Orbis Biosciences Meloxicam Products Offered
12.8.5 Orbis Biosciences Recent Development
12.9 Cellix Bio
12.9.1 Cellix Bio Corporation Information
12.9.2 Cellix Bio Business Overview
12.9.3 Cellix Bio Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Cellix Bio Meloxicam Products Offered
12.9.5 Cellix Bio Recent Development
12.10 Ligand Pharma
12.10.1 Ligand Pharma Corporation Information
12.10.2 Ligand Pharma Business Overview
12.10.3 Ligand Pharma Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Ligand Pharma Meloxicam Products Offered
12.10.5 Ligand Pharma Recent Development
12.11 SEDOR Pharma
12.11.1 SEDOR Pharma Corporation Information
12.11.2 SEDOR Pharma Business Overview
12.11.3 SEDOR Pharma Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.11.4 SEDOR Pharma Meloxicam Products Offered
12.11.5 SEDOR Pharma Recent Development
12.12 Heron Therapeutics
12.12.1 Heron Therapeutics Corporation Information
12.12.2 Heron Therapeutics Business Overview
12.12.3 Heron Therapeutics Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Heron Therapeutics Meloxicam Products Offered
12.12.5 Heron Therapeutics Recent Development
12.13 Pacira BioSciences
12.13.1 Pacira BioSciences Corporation Information
12.13.2 Pacira BioSciences Business Overview
12.13.3 Pacira BioSciences Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Pacira BioSciences Meloxicam Products Offered
12.13.5 Pacira BioSciences Recent Development
12.14 Sanofi
12.14.1 Sanofi Corporation Information
12.14.2 Sanofi Business Overview
12.14.3 Sanofi Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Sanofi Meloxicam Products Offered
12.14.5 Sanofi Recent Development
12.15 Eurofarma Laboratorio
12.15.1 Eurofarma Laboratorio Corporation Information
12.15.2 Eurofarma Laboratorio Business Overview
12.15.3 Eurofarma Laboratorio Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Eurofarma Laboratorio Meloxicam Products Offered
12.15.5 Eurofarma Laboratorio Recent Development
12.16 TerSera Therapeutics
12.16.1 TerSera Therapeutics Corporation Information
12.16.2 TerSera Therapeutics Business Overview
12.16.3 TerSera Therapeutics Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.16.4 TerSera Therapeutics Meloxicam Products Offered
12.16.5 TerSera Therapeutics Recent Development
12.17 Apotex
12.17.1 Apotex Corporation Information
12.17.2 Apotex Business Overview
12.17.3 Apotex Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Apotex Meloxicam Products Offered
12.17.5 Apotex Recent Development
12.18 Yung Shin Pharmaceutical
12.18.1 Yung Shin Pharmaceutical Corporation Information
12.18.2 Yung Shin Pharmaceutical Business Overview
12.18.3 Yung Shin Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Yung Shin Pharmaceutical Meloxicam Products Offered
12.18.5 Yung Shin Pharmaceutical Recent Development
12.19 Breckenridge Pharmaceutical
12.19.1 Breckenridge Pharmaceutical Corporation Information
12.19.2 Breckenridge Pharmaceutical Business Overview
12.19.3 Breckenridge Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Breckenridge Pharmaceutical Meloxicam Products Offered
12.19.5 Breckenridge Pharmaceutical Recent Development
12.20 Zydus Pharmaceuticals
12.20.1 Zydus Pharmaceuticals Corporation Information
12.20.2 Zydus Pharmaceuticals Business Overview
12.20.3 Zydus Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Zydus Pharmaceuticals Meloxicam Products Offered
12.20.5 Zydus Pharmaceuticals Recent Development
12.21 Unichem Pharmaceuticals
12.21.1 Unichem Pharmaceuticals Corporation Information
12.21.2 Unichem Pharmaceuticals Business Overview
12.21.3 Unichem Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Unichem Pharmaceuticals Meloxicam Products Offered
12.21.5 Unichem Pharmaceuticals Recent Development
12.22 Strides Pharma
12.22.1 Strides Pharma Corporation Information
12.22.2 Strides Pharma Business Overview
12.22.3 Strides Pharma Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Strides Pharma Meloxicam Products Offered
12.22.5 Strides Pharma Recent Development
12.23 Cipla
12.23.1 Cipla Corporation Information
12.23.2 Cipla Business Overview
12.23.3 Cipla Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Cipla Meloxicam Products Offered
12.23.5 Cipla Recent Development
12.24 Dr. Reddy's Laboratories
12.24.1 Dr. Reddy's Laboratories Corporation Information
12.24.2 Dr. Reddy's Laboratories Business Overview
12.24.3 Dr. Reddy's Laboratories Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Dr. Reddy's Laboratories Meloxicam Products Offered
12.24.5 Dr. Reddy's Laboratories Recent Development
12.25 Glenmark Pharmaceuticals
12.25.1 Glenmark Pharmaceuticals Corporation Information
12.25.2 Glenmark Pharmaceuticals Business Overview
12.25.3 Glenmark Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Glenmark Pharmaceuticals Meloxicam Products Offered
12.25.5 Glenmark Pharmaceuticals Recent Development
12.26 Teva
12.26.1 Teva Corporation Information
12.26.2 Teva Business Overview
12.26.3 Teva Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.26.4 Teva Meloxicam Products Offered
12.26.5 Teva Recent Development
12.27 PuraCap Pharmaceutical
12.27.1 PuraCap Pharmaceutical Corporation Information
12.27.2 PuraCap Pharmaceutical Business Overview
12.27.3 PuraCap Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.27.4 PuraCap Pharmaceutical Meloxicam Products Offered
12.27.5 PuraCap Pharmaceutical Recent Development
12.28 TARO
12.28.1 TARO Corporation Information
12.28.2 TARO Business Overview
12.28.3 TARO Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.28.4 TARO Meloxicam Products Offered
12.28.5 TARO Recent Development
12.29 Lupin Pharmaceuticals
12.29.1 Lupin Pharmaceuticals Corporation Information
12.29.2 Lupin Pharmaceuticals Business Overview
12.29.3 Lupin Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.29.4 Lupin Pharmaceuticals Meloxicam Products Offered
12.29.5 Lupin Pharmaceuticals Recent Development
12.30 Aurobindo Pharma
12.30.1 Aurobindo Pharma Corporation Information
12.30.2 Aurobindo Pharma Business Overview
12.30.3 Aurobindo Pharma Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.30.4 Aurobindo Pharma Meloxicam Products Offered
12.30.5 Aurobindo Pharma Recent Development
12.31 Shanghai Bolinger Ingelheim Pharmaceutical
12.31.1 Shanghai Bolinger Ingelheim Pharmaceutical Corporation Information
12.31.2 Shanghai Bolinger Ingelheim Pharmaceutical Business Overview
12.31.3 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.31.4 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Products Offered
12.31.5 Shanghai Bolinger Ingelheim Pharmaceutical Recent Development
12.32 Shanghai Zhaohui Pharmaceutical
12.32.1 Shanghai Zhaohui Pharmaceutical Corporation Information
12.32.2 Shanghai Zhaohui Pharmaceutical Business Overview
12.32.3 Shanghai Zhaohui Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.32.4 Shanghai Zhaohui Pharmaceutical Meloxicam Products Offered
12.32.5 Shanghai Zhaohui Pharmaceutical Recent Development
12.33 Sichuan Shenghe Pharmaceutical
12.33.1 Sichuan Shenghe Pharmaceutical Corporation Information
12.33.2 Sichuan Shenghe Pharmaceutical Business Overview
12.33.3 Sichuan Shenghe Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.33.4 Sichuan Shenghe Pharmaceutical Meloxicam Products Offered
12.33.5 Sichuan Shenghe Pharmaceutical Recent Development
12.34 Ningxia Kangya Pharmaceutical
12.34.1 Ningxia Kangya Pharmaceutical Corporation Information
12.34.2 Ningxia Kangya Pharmaceutical Business Overview
12.34.3 Ningxia Kangya Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.34.4 Ningxia Kangya Pharmaceutical Meloxicam Products Offered
12.34.5 Ningxia Kangya Pharmaceutical Recent Development
12.35 Yangtze Pharmaceutical Group
12.35.1 Yangtze Pharmaceutical Group Corporation Information
12.35.2 Yangtze Pharmaceutical Group Business Overview
12.35.3 Yangtze Pharmaceutical Group Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.35.4 Yangtze Pharmaceutical Group Meloxicam Products Offered
12.35.5 Yangtze Pharmaceutical Group Recent Development
12.36 Kunshan Longdeng Ruidi Pharmaceutical
12.36.1 Kunshan Longdeng Ruidi Pharmaceutical Corporation Information
12.36.2 Kunshan Longdeng Ruidi Pharmaceutical Business Overview
12.36.3 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.36.4 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Products Offered
12.36.5 Kunshan Longdeng Ruidi Pharmaceutical Recent Development
12.37 Jiangsu Yabang Epson Pharmaceutical
12.37.1 Jiangsu Yabang Epson Pharmaceutical Corporation Information
12.37.2 Jiangsu Yabang Epson Pharmaceutical Business Overview
12.37.3 Jiangsu Yabang Epson Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.37.4 Jiangsu Yabang Epson Pharmaceutical Meloxicam Products Offered
12.37.5 Jiangsu Yabang Epson Pharmaceutical Recent Development
12.38 Jiangsu Feima Pharmaceutical Co. , Ltd
12.38.1 Jiangsu Feima Pharmaceutical Co. , Ltd Corporation Information
12.38.2 Jiangsu Feima Pharmaceutical Co. , Ltd Business Overview
12.38.3 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.38.4 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Products Offered
12.38.5 Jiangsu Feima Pharmaceutical Co. , Ltd Recent Development
12.39 Zhejiang Xianju Pharmaceutical
12.39.1 Zhejiang Xianju Pharmaceutical Corporation Information
12.39.2 Zhejiang Xianju Pharmaceutical Business Overview
12.39.3 Zhejiang Xianju Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.39.4 Zhejiang Xianju Pharmaceutical Meloxicam Products Offered
12.39.5 Zhejiang Xianju Pharmaceutical Recent Development
12.40 Hainan All Star Pharmaceutical
12.40.1 Hainan All Star Pharmaceutical Corporation Information
12.40.2 Hainan All Star Pharmaceutical Business Overview
12.40.3 Hainan All Star Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
12.40.4 Hainan All Star Pharmaceutical Meloxicam Products Offered
12.40.5 Hainan All Star Pharmaceutical Recent Development
12.41 Hainan Aomeihua Pharmaceutical
12.42 Hunan Mingrui Pharmaceutical
12.43 Suzhou Sinochem Pharmaceutical
12.44 Qilu Pharmaceutical
12.45 Sichuan Luye Pharmaceutical
12.46 Shandong Xinhua Pharmaceutical
12.47 Guangdong Renkang Pharmaceutical
12.48 Hainan Selike Pharmaceutical
13 Meloxicam Manufacturing Cost Analysis
13.1 Meloxicam Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Meloxicam
13.4 Meloxicam Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Meloxicam Distributors List
14.3 Meloxicam Customers
15 Market Dynamics
15.1 Meloxicam Market Trends
15.2 Meloxicam Drivers
15.3 Meloxicam Market Challenges
15.4 Meloxicam Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Meloxicam Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Meloxicam Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Meloxicam Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Meloxicam Sales (KG) by Region (2016-2021)
Table 5. Global Meloxicam Sales Market Share by Region (2016-2021)
Table 6. Global Meloxicam Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Meloxicam Revenue Share by Region (2016-2021)
Table 8. Global Meloxicam Sales (KG) Forecast by Region (2022-2027)
Table 9. Global Meloxicam Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Meloxicam Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Meloxicam Revenue Share Forecast by Region (2022-2027)
Table 12. Global Meloxicam Sales (KG) of Key Companies (2016-2021)
Table 13. Global Meloxicam Sales Share by Company (2016-2021)
Table 14. Global Meloxicam Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Meloxicam Revenue Share by Company (2016-2021)
Table 16. Global Meloxicam by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meloxicam as of 2020)
Table 17. Global Meloxicam Average Price (US$/G) of Key Company (2016-2021)
Table 18. Manufacturers Meloxicam Manufacturing Sites and Area Served
Table 19. Manufacturers Meloxicam Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Meloxicam Sales (KG) by Type (2016-2021)
Table 22. Global Meloxicam Sales Share by Type (2016-2021)
Table 23. Global Meloxicam Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Meloxicam Price (US$/G) by Type (2016-2021)
Table 25. Global Meloxicam Sales Share by Type (2022-2027)
Table 26. Global Meloxicam Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Meloxicam Revenue Share by Type (2022-2027)
Table 28. Global Meloxicam Price (US$/G) by Type (2022-2027)
Table 29. Global Meloxicam Sales (KG) by Application (2016-2021)
Table 30. Global Meloxicam Sales Share by Application (2016-2021)
Table 31. Global Meloxicam Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Meloxicam Price (US$/G) by Application (2016-2021)
Table 33. Global Meloxicam Sales (KG) by Application (2022-2027)
Table 34. Global Meloxicam Sales Share by Application (2022-2027)
Table 35. Global Meloxicam Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Meloxicam Revenue Share by Application (2022-2027)
Table 37. Global Meloxicam Price (US$/G) by Application (2022-2027)
Table 38. North America Meloxicam Sales (KG) by Company (2016-2021)
Table 39. North America Meloxicam Sales Market Share by Company (2016-2021)
Table 40. North America Meloxicam Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Meloxicam Revenue Market Share by Company (2016-2021)
Table 42. North America Meloxicam Sales by Type (2016-2021) & (KG)
Table 43. North America Meloxicam Sales Market Share by Type (2016-2021)
Table 44. North America Meloxicam Sales by Type (2022-2027) & (KG)
Table 45. North America Meloxicam Sales Market Share by Type (2022-2027)
Table 46. North America Meloxicam Sales by Application (2016-2021) & (KG)
Table 47. North America Meloxicam Sales Market Share by Application (2016-2021)
Table 48. North America Meloxicam Sales by Application (2022-2027) & (KG)
Table 49. North America Meloxicam Sales Market Share by Application (2022-2027)
Table 50. Europe Meloxicam Sales (KG) by Company (2016-2021)
Table 51. Europe Meloxicam Sales Market Share by Company (2016-2021)
Table 52. Europe Meloxicam Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Meloxicam Revenue Market Share by Company (2016-2021)
Table 54. Europe Meloxicam Sales by Type (2016-2021) & (KG)
Table 55. Europe Meloxicam Sales Market Share by Type (2016-2021)
Table 56. Europe Meloxicam Sales by Type (2022-2027) & (KG)
Table 57. Europe Meloxicam Sales Market Share by Type (2022-2027)
Table 58. Europe Meloxicam Sales by Application (2016-2021) & (KG)
Table 59. Europe Meloxicam Sales Market Share by Application (2016-2021)
Table 60. Europe Meloxicam Sales by Application (2022-2027) & (KG)
Table 61. Europe Meloxicam Sales Market Share by Application (2022-2027)
Table 62. China Meloxicam Sales (KG) by Company (2016-2021)
Table 63. China Meloxicam Sales Market Share by Company (2016-2021)
Table 64. China Meloxicam Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Meloxicam Revenue Market Share by Company (2016-2021)
Table 66. China Meloxicam Sales by Type (2016-2021) & (KG)
Table 67. China Meloxicam Sales Market Share by Type (2016-2021)
Table 68. China Meloxicam Sales by Type (2022-2027) & (KG)
Table 69. China Meloxicam Sales Market Share by Type (2022-2027)
Table 70. China Meloxicam Sales by Application (2016-2021) & (KG)
Table 71. China Meloxicam Sales Market Share by Application (2016-2021)
Table 72. China Meloxicam Sales by Application (2022-2027) & (KG)
Table 73. China Meloxicam Sales Market Share by Application (2022-2027)
Table 74. Japan Meloxicam Sales (KG) by Company (2016-2021)
Table 75. Japan Meloxicam Sales Market Share by Company (2016-2021)
Table 76. Japan Meloxicam Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Meloxicam Revenue Market Share by Company (2016-2021)
Table 78. Japan Meloxicam Sales by Type (2016-2021) & (KG)
Table 79. Japan Meloxicam Sales Market Share by Type (2016-2021)
Table 80. Japan Meloxicam Sales by Type (2022-2027) & (KG)
Table 81. Japan Meloxicam Sales Market Share by Type (2022-2027)
Table 82. Japan Meloxicam Sales by Application (2016-2021) & (KG)
Table 83. Japan Meloxicam Sales Market Share by Application (2016-2021)
Table 84. Japan Meloxicam Sales by Application (2022-2027) & (KG)
Table 85. Japan Meloxicam Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Meloxicam Sales (KG) by Company (2016-2021)
Table 87. Southeast Asia Meloxicam Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Meloxicam Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Meloxicam Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Meloxicam Sales by Type (2016-2021) & (KG)
Table 91. Southeast Asia Meloxicam Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Meloxicam Sales by Type (2022-2027) & (KG)
Table 93. Southeast Asia Meloxicam Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Meloxicam Sales by Application (2016-2021) & (KG)
Table 95. Southeast Asia Meloxicam Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Meloxicam Sales by Application (2022-2027) & (KG)
Table 97. Southeast Asia Meloxicam Sales Market Share by Application (2022-2027)
Table 98. India Meloxicam Sales (KG) by Company (2016-2021)
Table 99. India Meloxicam Sales Market Share by Company (2016-2021)
Table 100. India Meloxicam Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Meloxicam Revenue Market Share by Company (2016-2021)
Table 102. India Meloxicam Sales by Type (2016-2021) & (KG)
Table 103. India Meloxicam Sales Market Share by Type (2016-2021)
Table 104. India Meloxicam Sales by Type (2022-2027) & (KG)
Table 105. India Meloxicam Sales Market Share by Type (2022-2027)
Table 106. India Meloxicam Sales by Application (2016-2021) & (KG)
Table 107. India Meloxicam Sales Market Share by Application (2016-2021)
Table 108. India Meloxicam Sales by Application (2022-2027) & (KG)
Table 109. India Meloxicam Sales Market Share by Application (2022-2027)
Table 110. Boehringer Ingelheim Corporation Information
Table 111. Boehringer Ingelheim Description and Business Overview
Table 112. Boehringer Ingelheim Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 113. Boehringer Ingelheim Meloxicam Product
Table 114. Boehringer Ingelheim Recent Development
Table 115. Baudax Corporation Information
Table 116. Baudax Description and Business Overview
Table 117. Baudax Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 118. Baudax Meloxicam Product
Table 119. Baudax Recent Development
Table 120. Perrigo Corporation Information
Table 121. Perrigo Description and Business Overview
Table 122. Perrigo Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 123. Perrigo Meloxicam Product
Table 124. Perrigo Recent Development
Table 125. Recro Pharma Corporation Information
Table 126. Recro Pharma Description and Business Overview
Table 127. Recro Pharma Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 128. Recro Pharma Meloxicam Product
Table 129. Recro Pharma Recent Development
Table 130. Iroko Pharma Corporation Information
Table 131. Iroko Pharma Description and Business Overview
Table 132. Iroko Pharma Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 133. Iroko Pharma Meloxicam Product
Table 134. Iroko Pharma Recent Development
Table 135. Zyla Life Sciences Corporation Information
Table 136. Zyla Life Sciences Description and Business Overview
Table 137. Zyla Life Sciences Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 138. Zyla Life Sciences Meloxicam Product
Table 139. Zyla Life Sciences Recent Development
Table 140. Axsome Therapeutics Corporation Information
Table 141. Axsome Therapeutics Description and Business Overview
Table 142. Axsome Therapeutics Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 143. Axsome Therapeutics Meloxicam Product
Table 144. Axsome Therapeutics Recent Development
Table 145. Orbis Biosciences Corporation Information
Table 146. Orbis Biosciences Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 147. Orbis Biosciences Description and Business Overview
Table 148. Orbis Biosciences Meloxicam Product
Table 149. Orbis Biosciences Recent Development
Table 150. Cellix Bio Corporation Information
Table 151. Cellix Bio Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 152. Cellix Bio Description and Business Overview
Table 153. Cellix Bio Meloxicam Product
Table 154. Cellix Bio Recent Development
Table 155. Ligand Pharma Corporation Information
Table 156. Ligand Pharma Description and Business Overview
Table 157. Ligand Pharma Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 158. Ligand Pharma Meloxicam Product
Table 159. Ligand Pharma Recent Development
Table 160. SEDOR Pharma Corporation Information
Table 161. SEDOR Pharma Description and Business Overview
Table 162. SEDOR Pharma Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 163. SEDOR Pharma Meloxicam Product
Table 164. SEDOR Pharma Recent Development
Table 165. Heron Therapeutics Corporation Information
Table 166. Heron Therapeutics Description and Business Overview
Table 167. Heron Therapeutics Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 168. Heron Therapeutics Meloxicam Product
Table 169. Heron Therapeutics Recent Development
Table 170. Pacira BioSciences Corporation Information
Table 171. Pacira BioSciences Description and Business Overview
Table 172. Pacira BioSciences Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 173. Pacira BioSciences Meloxicam Product
Table 174. Pacira BioSciences Recent Development
Table 175. Sanofi Corporation Information
Table 176. Sanofi Description and Business Overview
Table 177. Sanofi Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 178. Sanofi Meloxicam Product
Table 179. Sanofi Recent Development
Table 180. Eurofarma Laboratorio Corporation Information
Table 181. Eurofarma Laboratorio Description and Business Overview
Table 182. Eurofarma Laboratorio Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 183. Eurofarma Laboratorio Meloxicam Product
Table 184. Eurofarma Laboratorio Recent Development
Table 185. TerSera Therapeutics Corporation Information
Table 186. TerSera Therapeutics Description and Business Overview
Table 187. TerSera Therapeutics Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 188. TerSera Therapeutics Meloxicam Product
Table 189. TerSera Therapeutics Recent Development
Table 190. Apotex Corporation Information
Table 191. Apotex Description and Business Overview
Table 192. Apotex Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 193. Apotex Meloxicam Product
Table 194. Apotex Recent Development
Table 195. Yung Shin Pharmaceutical Corporation Information
Table 196. Yung Shin Pharmaceutical Description and Business Overview
Table 197. Yung Shin Pharmaceutical Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 198. Yung Shin Pharmaceutical Meloxicam Product
Table 199. Yung Shin Pharmaceutical Recent Development
Table 200. Breckenridge Pharmaceutical Corporation Information
Table 201. Breckenridge Pharmaceutical Description and Business Overview
Table 202. Breckenridge Pharmaceutical Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 203. Breckenridge Pharmaceutical Meloxicam Product
Table 204. Breckenridge Pharmaceutical Recent Development
Table 205. Zydus Pharmaceuticals Corporation Information
Table 206. Zydus Pharmaceuticals Description and Business Overview
Table 207. Zydus Pharmaceuticals Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 208. Zydus Pharmaceuticals Meloxicam Product
Table 209. Zydus Pharmaceuticals Recent Development
Table 210. Unichem Pharmaceuticals Corporation Information
Table 211. Unichem Pharmaceuticals Description and Business Overview
Table 212. Unichem Pharmaceuticals Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 213. Unichem Pharmaceuticals Meloxicam Product
Table 214. Unichem Pharmaceuticals Recent Development
Table 215. Strides Pharma Corporation Information
Table 216. Strides Pharma Description and Business Overview
Table 217. Strides Pharma Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 218. Strides Pharma Meloxicam Product
Table 219. Strides Pharma Recent Development
Table 220. Cipla Corporation Information
Table 221. Cipla Description and Business Overview
Table 222. Cipla Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 223. Cipla Meloxicam Product
Table 224. Cipla Recent Development
Table 225. Dr. Reddy's Laboratories Corporation Information
Table 226. Dr. Reddy's Laboratories Description and Business Overview
Table 227. Dr. Reddy's Laboratories Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 228. Dr. Reddy's Laboratories Meloxicam Product
Table 229. Dr. Reddy's Laboratories Recent Development
Table 230. Glenmark Pharmaceuticals Corporation Information
Table 231. Glenmark Pharmaceuticals Description and Business Overview
Table 232. Glenmark Pharmaceuticals Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 233. Glenmark Pharmaceuticals Meloxicam Product
Table 234. Glenmark Pharmaceuticals Recent Development
Table 235. Teva Corporation Information
Table 236. Teva Description and Business Overview
Table 237. Teva Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 238. Teva Meloxicam Product
Table 239. Teva Recent Development
Table 240. PuraCap Pharmaceutical Corporation Information
Table 241. PuraCap Pharmaceutical Description and Business Overview
Table 242. PuraCap Pharmaceutical Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 243. PuraCap Pharmaceutical Meloxicam Product
Table 244. PuraCap Pharmaceutical Recent Development
Table 245. TARO Corporation Information
Table 246. TARO Description and Business Overview
Table 247. TARO Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 248. TARO Meloxicam Product
Table 249. TARO Recent Development
Table 250. Lupin Pharmaceuticals Corporation Information
Table 251. Lupin Pharmaceuticals Description and Business Overview
Table 252. Lupin Pharmaceuticals Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 253. Lupin Pharmaceuticals Meloxicam Product
Table 254. Lupin Pharmaceuticals Recent Development
Table 255. Aurobindo Pharma Corporation Information
Table 256. Aurobindo Pharma Description and Business Overview
Table 257. Aurobindo Pharma Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 258. Aurobindo Pharma Meloxicam Product
Table 259. Aurobindo Pharma Recent Development
Table 260. Shanghai Bolinger Ingelheim Pharmaceutical Corporation Information
Table 261. Shanghai Bolinger Ingelheim Pharmaceutical Description and Business Overview
Table 262. Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 263. Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Product
Table 264. Shanghai Bolinger Ingelheim Pharmaceutical Recent Development
Table 265. Shanghai Zhaohui Pharmaceutical Corporation Information
Table 266. Shanghai Zhaohui Pharmaceutical Description and Business Overview
Table 267. Shanghai Zhaohui Pharmaceutical Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 268. Shanghai Zhaohui Pharmaceutical Meloxicam Product
Table 269. Shanghai Zhaohui Pharmaceutical Recent Development
Table 270. Sichuan Shenghe Pharmaceutical Corporation Information
Table 271. Sichuan Shenghe Pharmaceutical Description and Business Overview
Table 272. Sichuan Shenghe Pharmaceutical Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 273. Sichuan Shenghe Pharmaceutical Meloxicam Product
Table 274. Sichuan Shenghe Pharmaceutical Recent Development
Table 275. Ningxia Kangya Pharmaceutical Corporation Information
Table 276. Ningxia Kangya Pharmaceutical Description and Business Overview
Table 277. Ningxia Kangya Pharmaceutical Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 278. Ningxia Kangya Pharmaceutical Meloxicam Product
Table 279. Ningxia Kangya Pharmaceutical Recent Development
Table 280. Yangtze Pharmaceutical Group Corporation Information
Table 281. Yangtze Pharmaceutical Group Description and Business Overview
Table 282. Yangtze Pharmaceutical Group Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 283. Yangtze Pharmaceutical Group Meloxicam Product
Table 284. Yangtze Pharmaceutical Group Recent Development
Table 285. Kunshan Longdeng Ruidi Pharmaceutical Corporation Information
Table 286. Kunshan Longdeng Ruidi Pharmaceutical Description and Business Overview
Table 287. Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 288. Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Product
Table 289. Kunshan Longdeng Ruidi Pharmaceutical Recent Development
Table 290. Jiangsu Yabang Epson Pharmaceutical Corporation Information
Table 291. Jiangsu Yabang Epson Pharmaceutical Description and Business Overview
Table 292. Jiangsu Yabang Epson Pharmaceutical Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 293. Jiangsu Yabang Epson Pharmaceutical Meloxicam Product
Table 294. Jiangsu Yabang Epson Pharmaceutical Recent Development
Table 295. Jiangsu Feima Pharmaceutical Co. , Ltd Corporation Information
Table 296. Jiangsu Feima Pharmaceutical Co. , Ltd Description and Business Overview
Table 297. Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 298. Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Product
Table 299. Jiangsu Feima Pharmaceutical Co. , Ltd Recent Development
Table 300. Zhejiang Xianju Pharmaceutical Corporation Information
Table 301. Zhejiang Xianju Pharmaceutical Description and Business Overview
Table 302. Zhejiang Xianju Pharmaceutical Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 303. Zhejiang Xianju Pharmaceutical Meloxicam Product
Table 304. Zhejiang Xianju Pharmaceutical Recent Development
Table 305. Hainan All Star Pharmaceutical Corporation Information
Table 306. Hainan All Star Pharmaceutical Description and Business Overview
Table 307. Hainan All Star Pharmaceutical Meloxicam Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
Table 308. Hainan All Star Pharmaceutical Meloxicam Product
Table 309. Hainan All Star Pharmaceutical Recent Development
Table 310. Hainan Aomeihua Pharmaceutical Corporation Information
Table 311. Hunan Mingrui Pharmaceutical Corporation Information
Table 312. Suzhou Sinochem Pharmaceutical Corporation Information
Table 313. Qilu Pharmaceutical Corporation Information
Table 314. Sichuan Luye Pharmaceutical Corporation Information
Table 315. Shandong Xinhua Pharmaceutical Corporation Information
Table 316. Guangdong Renkang Pharmaceutical Corporation Information
Table 317. Hainan Selike Pharmaceutical Corporation Information
Table 318. Production Base and Market Concentration Rate of Raw Material
Table 319. Key Suppliers of Raw Materials
Table 320. Meloxicam Distributors List
Table 321. Meloxicam Customers List
Table 322. Meloxicam Market Trends
Table 323. Meloxicam Market Drivers
Table 324. Meloxicam Market Challenges
Table 325. Meloxicam Market Restraints
Table 326. Research Programs/Design for This Report
Table 327. Key Data Information from Secondary Sources
Table 328. Key Data Information from Primary Sources
List of Figures
Figure 1. Meloxicam Product Picture
Figure 2. Global Meloxicam Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Meloxicam Sales Market Share by Application in 2021 & 2027
Figure 6. Rheumatoid Arthritis Examples
Figure 7. Osteoarthritis Examples
Figure 8. Soft Tissue Inflammation Examples
Figure 9. Traumatic Pain Examples
Figure 10. Post-Operative Pain Examples
Figure 11. Other Examples
Figure 12. Global Meloxicam Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Meloxicam Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Meloxicam Sales (KG) Growth Rate (2016-2027)
Figure 15. Global Meloxicam Price Trends Growth Rate (2016-2027) (US$/G)
Figure 16. Global Meloxicam Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Meloxicam Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Meloxicam Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Meloxicam Sales (KG) Growth Rate (2016-2027)
Figure 20. Europe Meloxicam Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Meloxicam Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Meloxicam Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Meloxicam Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Meloxicam Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Meloxicam Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Meloxicam Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Meloxicam Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Meloxicam Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Meloxicam Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Meloxicam Players Market Share by Revenue in Meloxicam: 2016 & 2020
Figure 31. Meloxicam Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Meloxicam Revenue Share by Type (2016-2021)
Figure 33. Global Meloxicam Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Meloxicam Revenue Share by Application (2016-2021)
Figure 35. Global Meloxicam Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Meloxicam Sales Market Share by Type in 2020
Figure 37. North America Meloxicam Sales Market Share by Application in 2020
Figure 38. Europe Meloxicam Sales Market Share by Type in 2020
Figure 39. Europe Meloxicam Sales Market Share by Application in 2020
Figure 40. China Meloxicam Sales Market Share by Type in 2020
Figure 41. China Meloxicam Sales Market Share by Application in 2020
Figure 42. Japan Meloxicam Sales Market Share by Type in 2020
Figure 43. Japan Meloxicam Sales Market Share by Application in 2020
Figure 44. Southeast Asia Meloxicam Sales Market Share by Type in 2020
Figure 45. Southeast Asia Meloxicam Sales Market Share by Application in 2020
Figure 46. India Meloxicam Sales Market Share by Type in 2020
Figure 47. India Meloxicam Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Meloxicam
Figure 50. Manufacturing Process Analysis of Meloxicam
Figure 51. Meloxicam Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boehringer Ingelheim Baudax Perrigo Recro Pharma Iroko Pharma Zyla Life Sciences Axsome Therapeutics Orbis Biosciences Cellix Bio Ligand Pharma SEDOR Pharma Heron Therapeutics Pacira BioSciences Sanofi Eurofarma Laboratorio TerSera Therapeutics Apotex Yung Shin Pharmaceutical Breckenridge Pharmaceutical Zydus Pharmaceuticals Unichem Pharmaceuticals Strides Pharma Cipla Dr. Reddy's Laboratories Glenmark Pharmaceuticals Teva PuraCap Pharmaceutical TARO Lupin Pharmaceuticals Aurobindo Pharma Shanghai Bolinger Ingelheim Pharmaceutical Shanghai Zhaohui Pharmaceutical Sichuan Shenghe Pharmaceutical Ningxia Kangya Pharmaceutical Yangtze Pharmaceutical Group Kunshan Longdeng Ruidi Pharmaceutical Jiangsu Yabang Epson Pharmaceutical Jiangsu Feima Pharmaceutical Co. , Ltd Zhejiang Xianju Pharmaceutical Hainan All Star Pharmaceutical Hainan Aomeihua Pharmaceutical Hunan Mingrui Pharmaceutical Suzhou Sinochem Pharmaceutical Qilu Pharmaceutical Sichuan Luye Pharmaceutical Shandong Xinhua Pharmaceutical Guangdong Renkang Pharmaceutical Hainan Selike Pharmaceutical